Generation of an induced pluripotent stem cell line (SDASi001-A) from a Schimke immune-osseous dysplasia patient with SMARCAL1 mutations

Stem Cell Research - Tập 72 - Trang 103217 - 2023
Xingcui Wang1,2, Hongxia Zhang2, Xingbang Wang3, Weiran Zhou2, Linlin Dong2, Na Li4, Qiuxia He1
1Science and Technology Service Platform, Qilu University of Technology (Shandong Academy of Sciences), Ji’nan, Shandong, China
2Department of Rheumatology and Immunology, Children’s Hospital Affiliated to Shandong University, Ji’nan, Shandong, China
3Department of Geriatric Medicine, Qilu Hospital of Shandong University, Ji’nan, Shandong, China
4Dermatology Department, Jinan Central Hospital, Ji’nan, Shandong, China

Tài liệu tham khảo

Bansal, 2020, SMARCAL1, the annealing helicase and the transcriptional co-regulator, IUBMB Life, 72, 2080, 10.1002/iub.2354 Carroll, 2013, Schimke immunoosseous dysplasia associated with undifferentiated carcinoma and a novel SMARCAL1 mutation in a child, Pediatr. Blood Cancer, 60, E88, 10.1002/pbc.24542 Clewing, 2007, Schimke immunoosseous dysplasia: suggestions of genetic diversity, Hum. Mutat., 28, 273, 10.1002/humu.20432